IT
Inversion Therapeutics, Inc.
SEC filingBiotechnology · Burlingame, CA
Amount raised$6.9Msold at filing
Total offering$11.1M$4.2M still open
Investors in the raise4count reported to the SEC
FiledAug 27, 2025first sale Jun 20, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Samad Michael Wahid, M.D.Director
James A. Wells, Ph.D.Executive Officer, Director
Jeremy A. Caldwell, Ph.D.Director
William Michael Kavanaugh, M.D.Director
Executive officers, directors and promoters as listed on the Form D.